Wharton’s Jelly Mesenchymal Stem Cells: Differentiation Capacity Showing its Role in Bone Tissue Engineering

Wharton’s Jelly Mesenchymal Stem Cells: Differentiation Capacity Showing its Role in Bone Tissue Engineering

Wharton’s jelly mesenchymal stem cells (WJ-MSCs) is one of the best sources of mesenchymal stem cells (MSCs) that suggest both embryonic and adult stem cell characteristics. Before being applied in clinical application, the isolated MSCs should be tested to assess their quality, including differ...

Full description

Bibliographic Details
Main Authors:	Rizal Rizal, Rahimi Syaidah, Evelyn Evelyn, Alif Hafizh, Josh Frederich
Format:	Article
Language:	English
Published:	Universitas Indonesia 2020-11-01
Series:	International Journal of Technology
Subjects:	adipocytes chondrocytes differentiation capacity osteocytes wj-mscs
Online Access:	https://ijtech.eng.ui.ac.id/article/view/4309

Similar Items

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
by: Mathiyazhagan Rengasamy, et al.
Published: (2017-06-01)

The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
by: Li Ma, et al.
Published: (2023-08-01)

Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton’s Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury
by: Mai Barakat, et al.
Published: (2022-06-01)

Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications
by: Hana Drobiova, et al.
Published: (2023-06-01)

Nanosheets Based Approach to Elevate the Proliferative and Differentiation Efficacy of Human Wharton’s Jelly Mesenchymal Stem Cells
by: Suraj Kumar Singh, et al.
Published: (2022-05-01)

NR2F2 Regulates Cell Proliferation and Immunomodulation in Whartons’ Jelly Stem Cells
by: Li Ma, et al.
Published: (2022-08-01)

Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Na-Hee Lee, et al.
Published: (2020-09-01)

Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis
by: Lijie Pan, et al.
Published: (2021-09-01)

BKCa channels regulate the immunomodulatory properties of WJ-MSCs by affecting the exosome protein profiles during the inflammatory response
by: Ahui Song, et al.
Published: (2020-10-01)

In silico analysis of RNA and small RNA sequencing data from human BM-MSCs and differentiated osteocytes, chondrocytes and tenocytes
by: Srinivas V. Koduru, et al.
Published: (2021-01-01)

Effect of Serial Passage on Growth Kinetics, Biological Properties, and Differentiation into Adipocytes of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Rizal Rizal, et al.
Published: (2019-12-01)

Applications of Phytomedicines in Chondrocytes and Osteocytes Regeneration Therapy: Pre-Clinical and Clinical Studies
by: Mohammad Sheibani, et al.
Published: (2023-07-01)

The Effect of Proinflammatory Cytokines on the Proliferation, Migration and Secretory Activity of Mesenchymal Stem/Stromal Cells (WJ-MSCs) under 5% O<sub>2</sub> and 21% O<sub>2</sub> Culture Conditions
by: Aleksandra Wedzinska, et al.
Published: (2021-04-01)

Impact of Tranexamic Acid on Chondrocytes and Osteogenically Differentiated Human Mesenchymal Stromal Cells (hMSCs) In Vitro
by: Mike Wagenbrenner, et al.
Published: (2020-11-01)

Bioengineered skin constructs based on mesenchymal stromal cells and acellular dermal matrix exposed to inflammatory microenvironment releasing growth factors involved in skin repair
by: Luz Correa-Araujo, et al.
Published: (2023-10-01)

Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro
by: Nazneen Aslam, et al.
Published: (2021-03-01)

Interaction between Macrophages and Human Mesenchymal Stromal Cells Derived from Bone Marrow and Wharton’s Jelly—A Comparative Study
by: Marta Dymowska, et al.
Published: (2021-11-01)

Isolation and culture of umbilical vein mesenchymal stem cells
by: D.T. Covas, et al.
Published: (2003-09-01)

Comparison of Osteogenic and Chondrogenic Differentiation Ability of Buccal Fat Pad Derived Mesenchymal Stem Cells and Gingival Derived Cells
by: Hamid Ghaderi, et al.
Published: (2018-06-01)

Adipogenic gene expression in gilthead sea bream mesenchymal stem cells from different origin
by: Cristina Salmerón, et al.
Published: (2016-08-01)

Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro
by: Changbin Sun, et al.
Published: (2020-04-01)

Spatial learning and memory of young and aging rats following injection with human Wharton’s jelly‐mesenchymal stem cells
by: Berry Juliandi, et al.
Published: (2021-06-01)

Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development
by: Rawan Sabbah, et al.
Published: (2023-10-01)

Bone Formation in 2D Culture of Primary Cells
by: Edward L. Mertz, et al.
Published: (2023-01-01)

TM9SF4 is a novel regulator in lineage commitment of bone marrow mesenchymal stem cells to either osteoblasts or adipocytes
by: Libo Yu, et al.
Published: (2021-11-01)

Relationship between Oxytocin and Osteoarthritis: Hope or Despair?
by: Stephanie Ferrero, et al.
Published: (2021-10-01)

Comparative Studies on the Morphology of Chondrocytes, Adipocytes and Adipochondrocytes in New Zealand White Rabbits
by: Nashwa Araby, et al.
Published: (2023-08-01)

The RYR3 gene is involved in Wharton’s jelly derived mesenchymal stem cell treatment of Alzheimer’s disease in rats
by: Hirowati Ali, et al.
Published: (2023-05-01)

Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease
by: A. Crivaro, et al.
Published: (2023-09-01)

The Past, Present, and Future of Genetically Engineered Mouse Models for Skeletal Biology
by: Megan N. Michalski, et al.
Published: (2023-08-01)

Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study
by: B. Mehling, et al.
Published: (2022-10-01)

Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
by: Yingxin Zhang, et al.
Published: (2020-05-01)

Niches for Skeletal Stem Cells of Mesenchymal Origin
by: Anastasiia D. Kurenkova, et al.
Published: (2020-07-01)

Osteocytes contribute via nuclear receptor PPAR-alpha to maintenance of bone and systemic energy metabolism
by: Amit Chougule, et al.
Published: (2023-04-01)

Isolation and in vitro characterization of murine young-adult long bone skeletal progenitors
by: Shauni Loopmans, et al.
Published: (2022-08-01)

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption
by: L.A. Stechschulte, et al.
Published: (2016-08-01)

Persistency of Mesenchymal Stromal/Stem Cells in Lungs
by: Erica Ferrini, et al.
Published: (2021-07-01)

Dose-Response Tendon-Specific Markers Induction by Growth Differentiation Factor-5 in Human Bone Marrow and Umbilical Cord Mesenchymal Stem Cells
by: Maria Camilla Ciardulli, et al.
Published: (2020-08-01)

Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties
by: Shihua Wang, et al.
Published: (2018-06-01)

Intrathecal administration of mesenchymal stem cells in patients with adrenomyeloneuropathy
by: Tomasz Siwek, et al.
Published: (2024-02-01)